Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
The investments made by the government of Taiwan to create the Taiwan National Health Insurance Research Database continue to realize global population health benefits. The database has been used to conduct numerous studies of drug safety and efficacy, diagnostic test utility, disease progression, and risk factor prognosis, generating important clinical and public health insights that have implications not only for the people of Taiwan but also for people around the world.1 The article by Lee et al2 on fluoroquinolone safety in this issue of JAMA Internal Medicine adds to this knowledge.
Ross JS. Global Drug Safety Insights From Taiwan. JAMA Intern Med. 2015;175(11):1847. doi:10.1001/jamainternmed.2015.5402